chr9-137233223-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_001177316.2(SLC34A3):c.575C>T(p.Ser192Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000723 in 1,574,476 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.00055 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00074 ( 0 hom. )
Consequence
SLC34A3
NM_001177316.2 missense
NM_001177316.2 missense
Scores
4
9
6
Clinical Significance
Conservation
PhyloP100: 2.53
Genes affected
SLC34A3 (HGNC:20305): (solute carrier family 34 member 3) This gene encodes a member of SLC34A transporter family of proteins, and is expressed primarily in the kidney. It is involved in transporting phosphate into cells via sodium cotransport in the renal brush border membrane, and contributes to the maintenance of inorganic phosphate concentration in the kidney. Mutations in this gene are associated with hereditary hypophosphatemic rickets with hypercalciuria. Alternatively spliced transcript variants varying in the 5' UTR have been found for this gene.[provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-137233223-C-T is Pathogenic according to our data. Variant chr9-137233223-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 198610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-137233223-C-T is described in Lovd as [Likely_pathogenic]. Variant chr9-137233223-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC34A3 | NM_001177316.2 | c.575C>T | p.Ser192Leu | missense_variant | 7/13 | ENST00000673835.1 | NP_001170787.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC34A3 | ENST00000673835.1 | c.575C>T | p.Ser192Leu | missense_variant | 7/13 | NM_001177316.2 | ENSP00000501114 | P1 | ||
SLC34A3 | ENST00000361134.2 | c.575C>T | p.Ser192Leu | missense_variant | 7/13 | 2 | ENSP00000355353 | P1 | ||
SLC34A3 | ENST00000538474.5 | c.575C>T | p.Ser192Leu | missense_variant | 7/13 | 5 | ENSP00000442397 | P1 | ||
SLC34A3 | ENST00000673865.1 | c.575C>T | p.Ser192Leu | missense_variant | 7/10 | ENSP00000501101 |
Frequencies
GnomAD3 genomes AF: 0.000553 AC: 84AN: 151870Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
84
AN:
151870
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000436 AC: 80AN: 183402Hom.: 0 AF XY: 0.000419 AC XY: 42AN XY: 100328
GnomAD3 exomes
AF:
AC:
80
AN:
183402
Hom.:
AF XY:
AC XY:
42
AN XY:
100328
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000741 AC: 1054AN: 1422606Hom.: 0 Cov.: 36 AF XY: 0.000737 AC XY: 519AN XY: 704614
GnomAD4 exome
AF:
AC:
1054
AN:
1422606
Hom.:
Cov.:
36
AF XY:
AC XY:
519
AN XY:
704614
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000553 AC: 84AN: 151870Hom.: 0 Cov.: 32 AF XY: 0.000499 AC XY: 37AN XY: 74196
GnomAD4 genome
AF:
AC:
84
AN:
151870
Hom.:
Cov.:
32
AF XY:
AC XY:
37
AN XY:
74196
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
39
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:8
Likely pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 17, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 18, 2024 | Likely a European founder mutation that has been associated with a less severe HHRH phenotype in the homozygous state and increased risk for renal calcifications in the heterozygous state (PMID: 32150856); Published functional studies demonstrate that although this variant does not have a significant impact on membrane sorting of phosphate, it severely reduces transport activity (PMID: 30798342, 36596813); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 34805638, 32155322, 34666334, 30586318, 31672324, 16358215, 18996815, 19820004, 30798342, 16358214, 34743040, 35689455, 37432176, 36596813, 37414395, 24700880, 32150856) - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 192 of the SLC34A3 protein (p.Ser192Leu). This variant is present in population databases (rs199690076, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with hypophosphatemic rickets with hypercalciuria (HHRH) (PMID: 16358214, 18996815, 19820004). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 198610). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC34A3 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Nov 30, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | SLC34A3: PM3:Very Strong, PM2, PS3:Supporting - |
Likely pathogenic, no assertion criteria provided | research | Gharavi Laboratory, Columbia University | Sep 16, 2018 | - - |
Autosomal recessive hypophosphatemic bone disease Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | May 24, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 01, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Sep 30, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center | Nov 05, 2020 | The c.575C>T variant in the SLC34A3 gene is a homozygous missense variant, which results in the substitution of the a serine residue at the 192 position to leucine (p.Ser192Leu). This variant localizes to coding exon 7 of the SLC34A3 gene (13 exons total; NM_080877. In- silico analyses are inconsistent regarding predictions of the effect of this variant on protein structure and/or function (PROVEAN: neutral SIFT: damaging; PolyPhen-2: benign). This variant has been observed in the Genome Aggregation Database (gnomAD) at a low frequency (allele frequency = 0.0004615, no homozygotes), indicating it is not a common benign variant in the populations represented in this database. This variant has been reported to segregate with disease in multiple individuals with HHRH either in the homozygous state or with another SLC34A3 variant (PMIDs: 19820004, 18996815, 16358215, 16358214, 30798342). A different missense change at the same amino acid residue (S192W) has been described to be disease causing. - |
SLC34A3-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2024 | The SLC34A3 c.575C>T variant is predicted to result in the amino acid substitution p.Ser192Leu. This variant was reported in patients with hereditary hypophosphatemic rickets with hypercalciuria (Bergwitz et al. 2006. PubMed ID: 16358214; Lorenz-Depiereux et al. 2006. PubMed ID: 16358215; Page et al. 2008. PubMed ID: 18996815; Tencza et al. 2009. PubMed ID: 19820004; Schönauer et al. 2019. PubMed ID: 30798342; Table S1, Hureaux et al. 2019. PubMed ID: 31672324). Of note, some individuals heterozygous for this particular variant present with milder hypercalciuria and some signs of renal calcification (Tencza et al. 2009. PubMed ID: 19820004; Schönauer et al. 2019. PubMed ID: 30798342). This variant is reported in 0.096% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;.
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
P;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at